Last updated on October 2018

Korean Post-marketing Surveillance for Xeljanz


Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Division of Rheumatology
Seongnam-si, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

CHA Bundang Medical Center
Seongnam-si, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

Chosun University Hospital, Rheumatism Department
Dong Gu, Korea, Republic of
9.83miles
  Connect »